Australia markets closed

LakeShore Biopharma Co., Ltd (LSB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5468-0.0192 (-3.39%)
At close: 04:00PM EDT
0.5464 -0.00 (-0.07%)
After hours: 05:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.98M
Enterprise value 143.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.66
Price/book (mrq)1.34
Enterprise value/revenue 1.86
Enterprise value/EBITDA -22.21

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 3-58.56%
S&P500 52-week change 326.25%
52-week high 31.5000
52-week low 30.3500
50-day moving average 30.7904
200-day moving average 30.6430

Share statistics

Avg vol (3-month) 387.14k
Avg vol (10-day) 316.15k
Shares outstanding 5188.33M
Implied shares outstanding 6188.33M
Float 817.1M
% held by insiders 181.43%
% held by institutions 12.85%
Shares short (14 June 2024) 424.19k
Short ratio (14 June 2024) 40.35
Short % of float (14 June 2024) 40.02%
Short % of shares outstanding (14 June 2024) 40.01%
Shares short (prior month 15 May 2024) 438.89k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -66.76%
Operating margin (ttm)-49.50%

Management effectiveness

Return on assets (ttm)-10.14%
Return on equity (ttm)-77.80%

Income statement

Revenue (ttm)544.09M
Revenue per share (ttm)4.67
Quarterly revenue growth (yoy)-9.20%
Gross profit (ttm)N/A
EBITDA -297.52M
Net income avi to common (ttm)-333.56M
Diluted EPS (ttm)-0.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)222.61M
Total cash per share (mrq)2.39
Total debt (mrq)558.09M
Total debt/equity (mrq)117.61%
Current ratio (mrq)0.94
Book value per share (mrq)5.10

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A